was successfully added to your cart.

2014 February

President Hollande Excited about Exogen’s Technology Aimed at Preventing Cancer and Aging

Posted by | Announcements, News | No Comments
Exogen Co-Founders, Jon Tang and Sylvain Costes were among a select group of entrepreneurs invited to meet with French President Hollande during his visit to San Francisco, February 12, 2014.

Exogen Co-Founders, Jon Tang and Sylvain Costes were among a select group of entrepreneurs invited to meet with French President Hollande during his visit to San Francisco, February 12, 2014.

French President Hollande met with Exogen Co-Founders Sylvain Costes and Jon Tang during his visit with Silicon Valley entrepreneurs on February 12, 2014.  President Hollande asked about biotech startups in the US and their recipe for success.

President Hollande was excited to hear about Exogen’s long-term goal to develop blood-based kits that can be used at home to pre-screen for potential disease such as cancer and aging. Hollande congratulated Tang and Costes for their noble cause and mentioned his own recent pledge to invest 1.5 billion euros in easing access to cancer treatment in France over the next five years.

Exogen Co-Founders to Meet with French President Hollande

Posted by | Announcements, News | No Comments

Co-Founders Sylvain Costes, Ph.D. and Jon Tang, Ph.D.

 Exogen is one of ten startups invited to present their technology to President Hollande of France during his visit to Silicon Valley on February 12, 2014. Exogen’s aims are in line with many of the strategic goals of Hollande’s Innovation 2030 Commission, such as big data, personalized medicine, and innovation in the service of longevity and aging. President Hollande will be given the opportunity to see Exogen’s technology first-hand.